4 weeks (300500 mcg/day): ~12 vials 8 weeks (300500 mcg/day): ~23 vials Advanced (500750 mcg, 2/day): more vials needed Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 8 weeks (once daily): ~56 syringes 8 weeks (twice daily): ~112 syringes Bacteriostatic Water (10 mL bottles) Use 3.0 mL (gradual) or 2.0 mL (advanced) per 10 mg vial for reconstitution
Weve found that this direct approach yields the most consistent and reliable outcomes in research settings
About the Formulation This formulation combines two investigational peptide compounds: BPC-157 (Body Protection Compound-157) a synthetic peptide originally derived from a protective protein sequence identified in gastric juice and investigated in laboratory models of tissue biology and cellular signalling
Taken together, LA is a novel therapeutic in that it exhibits NSIT characteristics due to its nonsystemic, gut-restricted nature, and reaches the small intestine intact where it is hoped that it will have a therapeutic effect in human patients with celiac disease
BEST FOR Stubborn fat loss and metabolic support METHOD Oral capsule, taken daily FREQUENCY Daily, protocol length varies All information regarding products and services on this site are for educational purposes only